Boston Scientific's Jeffrey Mirviss sells $1.37 million in stock
Jeffrey B. Mirviss, Executive Vice President and President of Peripheral Interventions at Boston Scientific Corp (NYSE:BSX), ...
Stifel raises Williams Companies stock target to $62, maintains Buy
Stifel analysts adjusted their outlook on Williams Companies (NYSE:WMB) shares, raising the price target to $62 from $61, while reiterating a Buy rating. This adjustment follows the company's ...